awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48282763-86DE1F82-BEB5-49DF-B4D7-DDDA64C91284
Q48282763-86DE1F82-BEB5-49DF-B4D7-DDDA64C91284
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48282763-86DE1F82-BEB5-49DF-B4D7-DDDA64C91284
Combining anti-IgE with oral immunotherapy.
P2860
Q48282763-86DE1F82-BEB5-49DF-B4D7-DDDA64C91284
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48282763-86DE1F82-BEB5-49DF-B4D7-DDDA64C91284
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d14b985a5f4db25dcb7c613b5ca885f725f2414b
P2860
Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.